Luisa Pereira

Luisa Pereira

Auto-generated profile, based on publicly available information

Luisa Pereira

Serviço de Medicina paliativa, Hospital CUF Tejo, Lisboa, Portugal

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2023 in Acta Medica Portuguesa
Verified
Journal Article
Open access
PDF file
LALuís Brito Avô
Luís Brito Avô
LPLuísa Pereira
Luísa Pereira
AOAnabela Oliveira
Anabela Oliveira
FFFilipa Ferreira
Filipa Ferreira
PFPaulo Filipe
Paulo Filipe
SMSónia Moreira
Sónia Moreira
Acute porphyrias are a group of rare genetic metabolic disorders, caused by a defect in one of the enzymes involved in the heme biosynthesis, which results in an abnormally high accumulation of toxic intermediates. Acute porphyrias are characterized by potentially life-threatening attacks and, for some patients, by chronic manifestations that negatively impact daily functioning and quality of life. Clinical manifestations include a nonspecific set of gastrointestinal, neuropsychiatric, and/or cutaneous symptoms. Effective diagnostic methods are widely available, but due to their clinical heterogeneity and non-specificity, many years often elapse from symptom onset to diagnosis of acute porphyrias, delaying the treatment and increasing morbidity. Therefore, increased awareness of acute porphyrias among healthcare professionals is paramount to reducing disease burden. Treatment of acute porphyrias is centered on eliminating the potential precipitants, symptomatic treatment, and suppressing the hepatic heme pathway, through the administration of hemin or givosiran. Moreover, properly monitoring patients with acute porphyrias and their relatives is fundamental to preventing acute attacks, hospitalization, and long-term complications. Considering this, a multidisciplinary panel elaborated a consensus paper, aiming to provide guidance for an efficient and timely diagnosis of acute porphyrias, and evidence-based recommendations for treating and monitoring patients and their families in Portugal. To this end, all authors exhaustively reviewed and discussed the current scientific evidence on acute porphyrias available in the literature, between November 2022 and May 2023.

15 September 2025 in Gazeta Médica
Verified
Journal Article
Open access
PDF file
CTCatarina Távora
Catarina Távora
MSMaria Ana Sobral
Maria Ana Sobral
MFMaria Ferreira
Maria Ferreira
LPLuisa Pereira
Luisa Pereira
Hiccups are a very uncomfortable experience for palliative care patients and can greatly impact their quality of life.Physical manoeuvres can often terminate acute hiccups. Persistent and intractable hiccups that continue for progresdays or months are rare and difficult to treat. In situations where no reversible cause is identified, or where physical manoeuvres have failed, a systematic approach is required.The causes of hiccups may be divided into central and peripheral types. The drugs of choice for central causes of persistent hiccups are baclofen and gabapentin as an alternative, with metoclopramide recommended as the first choice for peripheral causes.The management of persistent hiccups presents a clinical challenge requiring further research on pathophysiology and treatment strategies. With this case report we provide a brief overview of the causes and treatment of this condition.